Study of COVID-19 drug pitched by Kenney results in 52 deaths - 2020-04-22
The promise of hydroxychloroquine, the anti-malaria drug that has been hyped up by right-wing politicians, is not materializing. A new study conducted in the United States shows that the drug is "associated with an increased risk of mortality."
The results were clear enough for the researchers to conclude that using the anti-malaria drug contributes to higher mortality. The patients who received hydroxychloroquine experienced a 28% death rate, whereas those getting regular care experienced an 11% death rate.
While the study is not a randomized controlled trial (the gold standard of medical experiments), it is the largest to look at hydroxychloroquine as a treatment for COVID-19.